Skip to main content
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1994 Aug;70(826):581–583. doi: 10.1136/pgmj.70.826.581

Severe dysphagia associated with major tranquillizer treatment.

T A Hughes 1, G Shone 1, G Lindsay 1, C M Wiles 1
PMCID: PMC2397702  PMID: 7937453

Abstract

A 56 year old patient with psychiatric complications of systemic lupus erythematosus developed severe dysphagia complicated by weight loss and aspiration. Following investigation it was concluded that the addition of haloperidol to her treatment was the major precipitating cause and withdrawal of the drug was followed by an objective improvement in swallowing. Patients taking major transquillizers may be at increased risk of severe dysphagia; regular observation of swallowing is suggested as a useful addition to the clinical examination of these patients.

Full text

PDF
581

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Craig T. J. Medication use and deaths attributed to asphyxia among psychiatric patients. Am J Psychiatry. 1980 Nov;137(11):1366–1373. doi: 10.1176/ajp.137.11.1366. [DOI] [PubMed] [Google Scholar]
  2. Craig T. J., Richardson M. A. Swallowing, tardive dyskinesia and anticholinergics. Am J Psychiatry. 1982 Aug;139(8):1083–1083. doi: 10.1176/ajp.139.8.1083a. [DOI] [PubMed] [Google Scholar]
  3. Massengill R., Jr, Nashold B. A swallowing disorder denoted in tardive dyskinesia patients. Acta Otolaryngol. 1969 Nov;68(5):457–458. doi: 10.3109/00016486909121585. [DOI] [PubMed] [Google Scholar]
  4. Newton-John H. Acute upper airway obstruction due to supraglottic dystonia induced by a neuroleptic. BMJ. 1988 Oct 15;297(6654):964–965. doi: 10.1136/bmj.297.6654.964. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES